[go: up one dir, main page]

MA32282B1 - Dérivés de 2-phényl-pyridine substitués - Google Patents

Dérivés de 2-phényl-pyridine substitués

Info

Publication number
MA32282B1
MA32282B1 MA33303A MA33303A MA32282B1 MA 32282 B1 MA32282 B1 MA 32282B1 MA 33303 A MA33303 A MA 33303A MA 33303 A MA33303 A MA 33303A MA 32282 B1 MA32282 B1 MA 32282B1
Authority
MA
Morocco
Prior art keywords
alternative
pyridine derivatives
phenyl pyridine
vascular
viscero
Prior art date
Application number
MA33303A
Other languages
Arabic (ar)
English (en)
Inventor
Eva Caroff
Kurt Hilpert
Francis Hubler
Emmanuel Meyer
Dorte Renneberg
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40756274&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA32282(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of MA32282B1 publication Critical patent/MA32282B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La présente invention concerne des composés de formule (i) dans laquelle r1, r2, r4, r5, ra, rb, n, w et z sont tels que définis dans la demande, leur préparation et leur utilisation comme antagonistes du récepteur p2y12 dans le traitement et/ou la prévention des maladies vasculaires périphériques, viscéro-vasculaires, hépato-vasculaires et réno-vasculaires, cardiovasculaires et cérébrovasculaires ou des états associés à l'agrégation plaquettaire, y compris la thrombose chez les humains et les autres mammifères.
MA33303A 2008-04-11 2010-11-01 Dérivés de 2-phényl-pyridine substitués MA32282B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2008051384 2008-04-11
PCT/IB2009/051499 WO2009125366A1 (fr) 2008-04-11 2009-04-09 Dérivés de 2-phényl-pyridine substitués

Publications (1)

Publication Number Publication Date
MA32282B1 true MA32282B1 (fr) 2011-05-02

Family

ID=40756274

Family Applications (1)

Application Number Title Priority Date Filing Date
MA33303A MA32282B1 (fr) 2008-04-11 2010-11-01 Dérivés de 2-phényl-pyridine substitués

Country Status (17)

Country Link
US (1) US8058263B2 (fr)
EP (1) EP2279191B1 (fr)
JP (1) JP5404768B2 (fr)
KR (1) KR101702670B1 (fr)
CN (1) CN101998961B (fr)
AR (1) AR071652A1 (fr)
AU (1) AU2009235033A1 (fr)
CA (1) CA2719636A1 (fr)
ES (1) ES2476045T3 (fr)
IL (1) IL208547A0 (fr)
MA (1) MA32282B1 (fr)
MX (1) MX2010010933A (fr)
NZ (1) NZ589168A (fr)
RU (1) RU2010145463A (fr)
TW (1) TW200944536A (fr)
WO (1) WO2009125366A1 (fr)
ZA (1) ZA201008053B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200640877A (en) 2005-04-28 2006-12-01 Actelion Pharmaceuticals Ltd Pyrimidine derivatives
AR063258A1 (es) 2006-10-13 2009-01-14 Actelion Pharmaceuticals Ltd Derivados de 2-aminocarbonil-piridina, una composicion farmaceutica que los contiene y su uso en la preparacion de un medicamento para el tratamiento de trastornos vasculares oclusivos.
CL2007003038A1 (es) 2006-10-25 2008-06-06 Actelion Pharmaceuticals Ltd Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos.
SI2225253T1 (sl) 2007-11-29 2012-09-28 Actelion Pharmaceuticals Ltd Derivati fosfonske kisline in njihova uporaba kot antagonisti receptorja P2Y12
AR071652A1 (es) 2008-04-11 2010-07-07 Actelion Pharmaceuticals Ltd Derivados 2- fenil-piridina substituidos
AR071653A1 (es) 2008-04-11 2010-07-07 Actelion Pharmaceuticals Ltd Derivados 2-fenil-4-ciclopropil-pirimidina
CA2756542C (fr) 2009-04-08 2017-08-22 Actelion Pharmaceuticals Ltd 6-(3-azabicyclo[3.1.0]hex-3-yl)-2-phenylpyrimidines
CN102405220B (zh) 2009-04-22 2015-05-27 埃科特莱茵药品有限公司 噻唑衍生物及其作为p2y12受体拮抗剂的用途
EP2322514A1 (fr) * 2009-11-11 2011-05-18 Bayer Schering Pharma Aktiengesellschaft Acide homoglutamique et dérivés d'acide glutamique
WO2013033178A1 (fr) 2011-08-30 2013-03-07 University Of Utah Research Foundation Procédés et compositions pour traiter le diabète insipide néphrogénique
KR102552795B1 (ko) 2016-09-22 2023-07-06 이도르시아 파마슈티컬스 리미티드 결정질 형태
JP7580918B2 (ja) 2017-03-15 2024-11-12 イドルシア・ファーマシューティカルズ・リミテッド Ｐ２ｙ１２受容体アンタゴニストの皮下投与

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5373586A (en) 1976-12-09 1978-06-30 Mitsubishi Chem Ind Ltd New penicillin derivatives
CA2020437A1 (fr) 1989-07-05 1991-01-06 Yoshihide Fuse Derive de cinnamamide
US6855715B1 (en) * 1999-06-14 2005-02-15 Eli Lilly And Company Serine protease inhibitors
US6861424B2 (en) * 2001-06-06 2005-03-01 Schering Aktiengesellschaft Platelet adenosine diphosphate receptor antagonists
CA2507657C (fr) * 2002-12-11 2011-05-31 Schering Aktiengesellschaft Composes de 2-aminocarbonyl-quinoline utilises en tant qu'antagonistes du recepteur de l'adenosine diphosphate des plaquettes
DK1611144T3 (da) 2003-04-09 2010-11-22 Wyeth Llc Derivater af 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl-phosphonsyre og deres avendelse som n-methyl-D-aspartat (NMDA)-receptor-antagonister
TW200640877A (en) * 2005-04-28 2006-12-01 Actelion Pharmaceuticals Ltd Pyrimidine derivatives
RU2423358C2 (ru) * 2005-10-21 2011-07-10 Актелион Фармасьютиклз Лтд Новые пиперазины в качестве антималярийных агентов
AR063258A1 (es) 2006-10-13 2009-01-14 Actelion Pharmaceuticals Ltd Derivados de 2-aminocarbonil-piridina, una composicion farmaceutica que los contiene y su uso en la preparacion de un medicamento para el tratamiento de trastornos vasculares oclusivos.
CL2007003038A1 (es) 2006-10-25 2008-06-06 Actelion Pharmaceuticals Ltd Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos.
SI2225253T1 (sl) 2007-11-29 2012-09-28 Actelion Pharmaceuticals Ltd Derivati fosfonske kisline in njihova uporaba kot antagonisti receptorja P2Y12
WO2009080227A2 (fr) 2007-12-26 2009-07-02 Sanofi-Aventis Dérivés de pyrazole-carboxamide utiles en tant qu'antagonistes de p2y12
JP5504171B2 (ja) 2007-12-26 2014-05-28 サノフイ Ｐ２ｙ１２アンタゴニストとしてのヘテロサイクリックピラゾール−カルボキサミド
AR071652A1 (es) 2008-04-11 2010-07-07 Actelion Pharmaceuticals Ltd Derivados 2- fenil-piridina substituidos
AR071653A1 (es) 2008-04-11 2010-07-07 Actelion Pharmaceuticals Ltd Derivados 2-fenil-4-ciclopropil-pirimidina
CA2756542C (fr) 2009-04-08 2017-08-22 Actelion Pharmaceuticals Ltd 6-(3-azabicyclo[3.1.0]hex-3-yl)-2-phenylpyrimidines
CN102405220B (zh) 2009-04-22 2015-05-27 埃科特莱茵药品有限公司 噻唑衍生物及其作为p2y12受体拮抗剂的用途

Also Published As

Publication number Publication date
CA2719636A1 (fr) 2009-10-15
AR071652A1 (es) 2010-07-07
KR20100129788A (ko) 2010-12-09
CN101998961B (zh) 2014-06-25
US8058263B2 (en) 2011-11-15
EP2279191A1 (fr) 2011-02-02
US20110046089A1 (en) 2011-02-24
RU2010145463A (ru) 2012-05-20
ZA201008053B (en) 2014-04-30
TW200944536A (en) 2009-11-01
JP2011516540A (ja) 2011-05-26
WO2009125366A1 (fr) 2009-10-15
CN101998961A (zh) 2011-03-30
KR101702670B1 (ko) 2017-02-06
MX2010010933A (es) 2010-11-05
AU2009235033A1 (en) 2009-10-15
EP2279191B1 (fr) 2014-04-02
NZ589168A (en) 2012-06-29
ES2476045T3 (es) 2014-07-11
JP5404768B2 (ja) 2014-02-05
IL208547A0 (en) 2010-12-30

Similar Documents

Publication Publication Date Title
MA32282B1 (fr) Dérivés de 2-phényl-pyridine substitués
MA34650B1 (fr) Antagonistes du récepteur cgrp de pipéridinone carboxamide azaindane
MA32277B1 (fr) Derives de 2-phenyl-4- cyclopropyl-pyrimidine
MA33277B1 (fr) Dérivés de thiazole et leur utilisation comme antagonistes des récepteurs p2y12
MA33123B1 (fr) 2-acetamido-5-aryl-1,2,4-triazolones substitues et leur utilisation
TN2009000324A1 (fr) Composes tricycliques et leur utilisation comme modulateurs du recepteur de glucocorticoides
MA31952B1 (fr) Pyrrolopyrimidines et pyrrolopyridines
MA32226B1 (fr) Compositions et leurs procedes de preparation et d'utilisation
MA30914B1 (fr) Dihydropyrazolones substituees utilisees dans le traitement de maladies cardiovasculaires et hematologiques.
MA33038B1 (fr) Procedes de preparation d'inhibiteurs des jak et composes intermediaires apparentes
MA33155B1 (fr) Composes organiques et leurs utilisations
MA28680B1 (fr) 3-aminocyclopentanecarboxamides utiles comme modulateurs de récepteurs de chimiokines
MA31076B1 (fr) Dérivés de l'isoquinoléine et de l'isoquinoléinone substitués par une cycloalkylamine.
MA30077B1 (fr) 3-aminocyclopentanecarboxamides servant de modulateurs de recepteurs de chimiokines
TN2010000230A1 (fr) Agonistes nouveaux des recepteurs de glucocorticoides
MA31949B1 (fr) Dérivés d'aminotriazole comme agonistes d'alx
MA31024B1 (fr) Nouveaux derives de l'isoquinoleine et de l'isoquinoleinone substituees
MA35576B1 (fr) Nouveaux composés
MA28681B1 (fr) 3-aminocyclopentanecarboxamides utiles comme modulateurs de récepteurs de chimiokines
NO20092470L (no) Substituerte diazepanforbindelser som orexinreseptorantagonister
MA33178B1 (fr) Pipéridines substituées comme antagonistes de ccr3
TN2009000524A1 (en) Novel dicarboxylic acid derivatives as s1p1 receptor agonists
WO2006114774A3 (fr) Derives de pyrimidine
MA37891B1 (fr) Alcoxypyrazoles comme activateurs de guanylate cyclase soluble
MX2009003724A (es) Derivados de 2-aminocarbonil-piridina.